Brief: Cymabay Reports First Quarter 2022 Financial Results And Provides Corporate Update
12/05/2022 22:29
May 12 (Reuters) - Cymabay Therapeutics Inc CBAY.O :
* CYMABAY REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES CORPORATE UPDATE
* QTRLY LOSS PER SHARE $0.32
* Q1 EARNINGS PER SHARE VIEW $-0.31 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX45Wzwv
Further company coverage: CBAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CymaBay Therapeutics
See all newsBrief: CymaBay Says EMA Accepted For Review The Marketing Authorization Application For Seladelpar
U.S. RESEARCH ROUNDUP-Bruker Corp, Cymabay Therapeutics, SSR Mining
U.S. RESEARCH ROUNDUP-An2 Therapeutics, Par Technology, Trimble
U.S. STOCKS ON THE MOVE-Perpetua Resources, Nvidia, SiriusXM
U.S. STOCKS ON THE MOVE-Lowe's, Bit Digital Snap